Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004582421 | SCV005067782 | pathogenic | Primary pulmonary hypertension | 2023-08-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the BMPR2 protein in which other variant(s) (Deletion (Exons 2-3)) have been determined to be pathogenic (PMID: 18503968, 21801371). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. A similar copy number variant has been observed in individual(s) with pulmonary arterial hypertension (PMID: 26387786). This variant is a gross deletion of the genomic region encompassing exon(s) 2-9 of the BMPR2 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |